An Update On Gilead's 2015 Outlook $GILD
http://ift.tt/1L75ca9
Nice article. States Gilead will receive many medical exceptions in ESI due to providers preferring its regimen. Also says Abbvie may see a 10% market share. Gilead also dominating in Europe.
Abbvie dealt a hand that was not as good as what Gilead had. Period! No amount of groveling is going to change that. Abbvie better stick to professionalism and asking for what we can win on and NOT annoying the crap out of providers and clinics to write for VPak when 9/10 times they prefer Harvoni and will write a medical exception to get what they want. No need for HSE's or AE's in this division....Gilead already providing wonderful programs for screening etc. a lot of overpaid people that cannot do much...and if they do ....they're only helping our competitor? Make changes Abbvie - starting from the top down. The fat lady is coming onto the stage to sing her final tune. Get ready!
http://ift.tt/1L75ca9
Nice article. States Gilead will receive many medical exceptions in ESI due to providers preferring its regimen. Also says Abbvie may see a 10% market share. Gilead also dominating in Europe.
Abbvie dealt a hand that was not as good as what Gilead had. Period! No amount of groveling is going to change that. Abbvie better stick to professionalism and asking for what we can win on and NOT annoying the crap out of providers and clinics to write for VPak when 9/10 times they prefer Harvoni and will write a medical exception to get what they want. No need for HSE's or AE's in this division....Gilead already providing wonderful programs for screening etc. a lot of overpaid people that cannot do much...and if they do ....they're only helping our competitor? Make changes Abbvie - starting from the top down. The fat lady is coming onto the stage to sing her final tune. Get ready!
Gilead crushes Abbvie at their own game!
Aucun commentaire:
Enregistrer un commentaire